MEDVi GLP-1 Clinic Review: A Flat Rate With Options

Finding an online GLP-1 clinic is often a maze of hidden fees, flashy promises, and fine print. Some clinics advertise instant results but make you wait weeks for approval. Others list a great price, then double it at checkout.

Could MEDVi, the latest telehealth clinic that claims to bridge the Quality-Price Gap without cutting corners, help you escape the maze—or is it just another shortcut with clever marketing? 

This article is for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before starting any new treatment.

📋Our Score: 5/5

What Is MEDVi?

MEDVi is a telehealth clinic based in Newark, Delaware, that focuses exclusively on making GLP-1 medications accessible and affordable for individuals seeking medical weight-loss support. Rather than offering dozens of unrelated services, MEDVi keeps things simple by connecting patients to licensed providers and delivering prescriptions quickly and securely.

What makes MEDVi stand out from other online clinics is its speed and convenience. Partnering with Belmar Pharma Solutions and Beluga Health, MEDVi helps most patients get approved and start treatment within just a few days, instead of waiting weeks for care.

The clinic specializes in compounded versions of semaglutide and tirzepatide, which use the same active drug molecules found in Ozempic®, Wegovy®, Mounjaro®, and Zepbound®.

However, compounded medications are not FDA approved, may differ in formulation, concentration, and quality from brand-name products, and carry additional risks. When made correctly, these compounded alternatives can be less expensive than brand-name medications.

How Does MEDVi Work?

Step 1: Provide Your Medical History

Start by filling out a short but detailed health questionnaire about your medical history, current medications, and weight-loss goals. This helps your provider determine if GLP-1 treatment is right for you.

Step 2: Medical Review & Provider Consultation

A licensed provider reviews your assessment, usually within 24 hours, and decides on your eligibility. Lab work isn’t always required, but if you have conditions like thyroid issues or diabetes, MEDVi includes testing through partner labs like Quest Diagnostics.

Keep in mind that some states’ telehealth laws require face-to-face consultations, even virtually. So while MEDVi providers review your medical history and may approve your prescription remotely, this may not be the case for everyone.

Step 3: Get Your Personalized Plan

Once approved, your provider creates a treatment plan that outlines your medication, dosing schedule, and what to expect during your first few weeks on GLP-1 therapy.

Step 4: Receive Your Medication

Your prescription is shipped directly to your home in discreet, temperature-controlled packaging. Most patients receive their medication within a few days of approval.

Step 5: Begin Treatment With Ongoing Support 

Start your prescribed regimen and access 24/7 support via unlimited messaging for questions about side effects, dosage, or progress. Providers check in regularly and adjust your dose or medication as needed.

Step 6: Continue With Follow-Ups

Ongoing monitoring ensures your treatment stays safe and effective. Most patients complete follow-up labs every 3–6 months to track kidney function, blood sugar, and overall progress.

Treatment Options at MEDVi

• Weekly GLP-1 injections: Ozempic; compounded semaglutide; compounded tirzepatide

• Daily oral GLP-1s: compounded semaglutide; compounded tirzepatide 

A note on compounded meds: The FDA has issued cautions regarding compounded GLP-1 medications due to risks like contamination, incorrect concentrations, and temperature mishandling that can affect effectiveness.^[1] 

Patients should ensure their medication comes from a licensed US compounding pharmacy that follows USP standards, arrives properly refrigerated, and looks consistent with their provider’s prescription. If anything seems unusual, contact your provider before use.

MEDVi Pricing: Transparent Plans With Flexible Options

MEDVi’s GLP-1 program runs on a straightforward cash-pay model, making prescription weight-loss treatment simple, affordable, and easy to manage without hidden fees or long-term contracts.

Initial lab test: Included when medically necessary 

If your provider determines labs are needed before starting treatment, MEDVi partners with Quest Diagnostics for easy access.

Monthly medication prices: 

Compounded semaglutide 

• Injections: $179 first month, then $299/month
• Tablets: $249 first month, then $349/month

Compounded tirzepatide

• Injections: $349/month
• Tablets: $279 first month, then $399/month

Ozempic: starts at $1,999/month

MEDVi operates entirely on a cash-pay basis and does not accept insurance for consultations or medications. Patients can use HSA or FSA cards for payment, but coverage isn’t guaranteed. MEDVi also offers a results-based guarantee, so if you follow the program for at least five months without achieving weight loss, you may qualify for a refund.

How it compares:

MEDVi focuses on affordability and speed without compromising medical oversight. It partners with licensed providers nationwide and maintains clear and consistent pricing, which sets it apart from programs that add hidden fees for follow-ups or lab tests.

• Shed offers compounded semaglutide and tirzepatide starting at $199–$699/month and also provides Wegovy and Zepbound for those who prefer brand-name options. Labs and coaching cost extra unless you upgrade to a premium plan.
• Henry Meds provides compounded semaglutide from $249/month, including consultation and shipping, but doesn’t offer 24/7 provider support or a results-based guarantee like MEDVi.
• Found emphasizes behavioral coaching and community support, with plans starting at $39/month (medication not included). While it’s strong on lifestyle guidance, medical oversight isn’t as hands-on as MEDVi’s.
• Ro Body Program includes compounded semaglutide, brand-name medications, and weekly coaching, but the combined membership and medication costs can be significantly higher than MEDVi’s fixed, all-inclusive rates.

Read more about affordable online weight-loss clinics.

What’s Included With MEDVi?

What’s Not Included?

Here’s what you won’t find built into MEDVi’s plans:

MEDVi is a strong option for those who want affordable GLP-1 access and fast approvals without complicated programs. But if you’re looking for brand-name medications and coaching support, Ro Body Program offers both.

True Value Score™: A-

Lab Testing: What Gets Measured and Why It Matters

MEDVi’s providers may order baseline labs before starting GLP-1 treatment to confirm that the medication is safe and appropriate for you. These labs are typically completed through Quest Diagnostics, and if you’ve had recent testing, you can usually submit those results instead.

Here’s what the standard labs usually check:

• Hemoglobin A1c (HbA1c): measures long-term blood sugar control and screens for diabetes or insulin resistance^[2]
• Fasting glucose: gives a snapshot of your current blood sugar level to assess metabolic health^[3]
• Lipid panel (HDL, LDL, triglycerides): monitors cholesterol and cardiovascular health^[4]
• Liver enzymes (ALT, AST): checks for any liver issues that may affect medication processing^[5]
• Kidney function (creatinine, BUN): checks your baseline kidney health and helps your provider monitor for problems, especially if vomiting, diarrhea, or dehydration occur during treatment^[6]
• Thyroid function (TSH): identifies thyroid imbalances that might affect metabolism^[7]
• Complete blood count (CBC): provides a general picture of overall health and flags possible deficiencies or infections^[8]

How often do you need labs?

MEDVi may require initial lab work before starting treatment to ensure GLP-1s are safe and appropriate for you. Follow-up tests are typically recommended every few months or as directed by your provider to monitor progress and overall health.

🎯 Who Should Use MEDVi?

MEDVi is a great fit for adults who want fast, affordable access to GLP-1 treatment without all the extras that come with full-service programs.

Unlike full-scale programs with high monthly fees or long onboarding times, MEDVi focuses on speed, transparency, and results. You’ll work with licensed providers who review your case within 24 hours, helping you start treatment in days, not weeks.

Because MEDVi keeps things straightforward, it’s ideal for patients who prefer simple, results-driven care.

If you’re not looking for in-depth coaching, MEDVi keeps things simple. You get what you need: safe prescriptions, ongoing communication, and medical oversight. No arbitrary membership fees or subscription terms.

MEDVi is also well-suited for those who value flexibility and constant support.

They offer 24/7 unlimited provider messaging, so you can reach out anytime about side effects, dosing, or progress, and don’t need to wait for appointments.

It’s especially perfect for cost-conscious patients who don’t need brand-name medications.

By partnering with licensed compounding pharmacies, MEDVi providers compounded semaglutide and tirzepatide at a lower cost than brand-name options, making treatment more accessible.

Finally, MEDVi is best for people who prefer an independent approach.

You’ll get professional guidance and follow-ups, but day-to-day habits and lifestyle changes are up to you, so it is perfect if you want medical support without a structured coaching program.

🚫 Who Is MEDVi Not For?

MEDVi isn’t the right fit for everyone, especially if you’re looking for a full lifestyle or coaching-based program. While providers offer basic guidance, there’s no structured nutrition counseling or behavioral support for long-term habit change. If you want hands-on coaching, a program like Calibrate might be a better match.

MEDVi also isn’t ideal for patients who rely on insurance coverage. The clinic operates on a cash-pay model and doesn’t assist with prior authorizations or insurance billing, so all payments are out of pocket.

How Does MEDVi Compare to Other Clinics?

When weighing MEDVi against competitors, here’s how things shake out:

Swipe to scroll the table below →

Real User Experience With MEDVi

Happy patients say MEDVi makes starting GLP-1 treatment quick and straightforward. Providers communicate clearly, answer every question, and ensure there are no hidden costs.

However, not all feedback is positive. Some patients report occasional computer glitches, double charges, or providers missing scheduled appointments. While these issues are rare, they’ve caused frustration for users expecting a smoother telehealth experience.

Final Verdict

MEDVi provides a simple, practical, and highly accessible path to medically supervised GLP-1 treatment. MEDVi stands out with its commitment to patient availability, offering 24/7 support nationwide alongside trustworthy care from licensed providers and convenient prescription delivery.

While it lacks structured coaching and can occasionally run into tech hiccups or billing issues, MEDVi still provides solid value with clear communication and dependable medical oversight.

For patients who want straightforward, results-driven care from licensed providers, MEDVi delivers reliable weight-loss support with transparency and speed.

FAQs

Sources

1. US Food & Drug Administration. (2025, September 25). FDA’s concerns with unapproved GLP-1 drugs used for weight loss. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
2. Eyth, E., Zubair, M., & Naik, R. (2025). Hemoglobin A1c. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK549816/
3. Rao, S. S., Disraeli, P., & McGregor, T. (2004). Impaired glucose tolerance and impaired fasting glucose. American Family Physician, 69(8), 1961–1968. https://www.aafp.org/pubs/afp/issues/2004/0415/p1961.pdf
4. Chan, D. C., Watts, G. F., Ng, T. W. K., Yamashita, S., & Barrett, P. H. R. (2008). Effect of weight loss on markers of triglyceride‐rich lipoprotein metabolism in the metabolic syndrome. European Journal of Clinical Investigation, 38(10), 743–751. https://doi.org/10.1111/j.1365-2362.2008.02019.x
5. Kanwal, F., Kramer, J. R., Li, L., Yang, Y. X., Cao, Y., Yu, X., Samuel, R., Ali, B., Desiderio, R., Cholankeril, G., & Bajaj, M. (2024). GLP-1 receptor agonists and risk for cirrhosis and related complications in patients with metabolic dysfunction-associated steatotic liver disease. JAMA Internal medicine, 184(11), 1314–1323. https://doi.org/10.1001/jamainternmed.2024.4661
6. Avila, M., Mora Sánchez, M. G., Bernal Amador, A. S., & Paniagua, R. (2025). The metabolism of creatinine and its usefulness to evaluate kidney function and body composition in clinical practice. Biomolecules, 15(1), 41. https://doi.org/10.3390/biom15010041
7. Feier, C. V. I., Vonica, R. C., Faur, A. M., Streinu, D. R., & Muntean, C. (2024). Assessment of thyroid carcinogenic risk and safety profile of GLP1-RA semaglutide (Ozempic) therapy for diabetes mellitus and obesity: A systematic literature review. International Journal of Molecular Sciences, 25(8), 4346. https://doi.org/10.3390/ijms25084346
8. Seo, I. H., & Lee, Y. J. (2022). Usefulness of complete blood count (CBC) to assess cardiovascular and metabolic diseases in clinical settings: a comprehensive literature review. Biomedicines, 10(11), 2697. https://doi.org/10.3390/biomedicines10112697
9. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T., Wadden, T. A., & Wharton, S. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183